News
The dollar has weakened against rival currencies since Trump started his second term. One strategist says the US currency is ...
Liverpool may be champions, but Arsenal very much have points to play for - our writers on the two teams look ahead to Sunday ...
Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its ...
For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...
The 21st Dublin Dance Festival kicks off on Tuesday and as part of the celebrations, a new national all-island dance company ...
3d
Medical Device Network on MSNRoche introduces diagnostic test for liver fibrosis severity assessmentRoche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...
Germain, in collaboration with Novotel, is delighted to unveil the Legendary Room celebrating Alain Roche at Novotel Valencia ...
Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...
As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...
11d
Medical Device Network on MSNFDA grants breakthrough status to Roche’s VENTANA TROP2 deviceThe US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.
A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results